Es gab 39 kürzliche Insider-Transaktionen für Elicio Therapeutics, Inc. (ELTX), darunter 34 Käufe und 4 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $26.63M und die gesamten Insider-Verkäufe auf $20M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Haqq Christopher, Shah Preetam, Connelly Robert. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ELTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-02 |
Haqq Christopher |
See Remarks |
RSU-Zuteilung |
50,900 |
$8.10 |
$412.29K |
50,900 |
| 2026-02-02 |
Shah Preetam |
See Remarks |
RSU-Zuteilung |
24,000 |
- |
- |
24,000 |
| 2026-02-02 |
Connelly Robert |
CEO, President and Director |
RSU-Zuteilung |
73,600 |
- |
- |
120,570 |
| 2026-02-02 |
Demuth Peter |
Chief Scientific Officer |
RSU-Zuteilung |
20,800 |
- |
- |
21,543 |
| 2025-12-09 |
Demuth Peter |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
362 |
$4.41 |
$1.6K |
- |
| 2025-06-03 |
Chudnovsky Yekaterina |
10 Percent Owner |
RSU-Zuteilung |
103,225 |
$7.75 |
$799.99K |
103,225 |
| 2025-05-19 |
Ruffolo Robert R |
Director |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Adams Julian |
Director |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Wilson Karen J |
Director |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Venkatesan Jay |
Director |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Nissenson Allen |
Director |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Ashe Carol Gail |
Director |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Chudnovsky Yekaterina |
10 Percent Owner |
RSU-Zuteilung |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-04-15 |
Shah Preetam |
See Remarks |
RSU-Zuteilung |
191,624 |
$4.98 |
$954.29K |
191,624 |
| 2025-03-24 |
Shah Preetam |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-03-05 |
Chudnovsky Yekaterina |
10 Percent Owner |
Umwandlung (Verkauf) |
3,442,341 |
$5.81 |
$20M |
- |
| 2025-02-03 |
Haqq Christopher |
See Remarks |
RSU-Zuteilung |
44,000 |
$8.92 |
$392.48K |
44,000 |
| 2025-02-03 |
Connelly Robert |
CEO, President and Director |
RSU-Zuteilung |
121,600 |
$8.92 |
$1.08M |
121,600 |
| 2025-02-03 |
Demuth Peter |
Chief Scientific Officer |
RSU-Zuteilung |
44,400 |
$8.92 |
$396.05K |
44,400 |
| 2024-12-16 |
Demuth Peter |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
381 |
$4.41 |
$1.68K |
- |
| 2024-11-26 |
Venkatesan Jay |
Director |
Optionsausübung (ITM) |
50,000 |
$0.01 |
$500.00 |
- |
| 2024-11-21 |
Ruffolo Robert R |
Director |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Adams Julian |
Director |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Wilson Karen J |
Director |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Venkatesan Jay |
Director |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Nissenson Allen |
Director |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Ashe Carol Gail |
Director |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Chudnovsky Yekaterina |
10 Percent Owner |
RSU-Zuteilung |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-09-30 |
Haqq Christopher |
See Remarks |
RSU-Zuteilung |
28,200 |
$5.03 |
$141.85K |
28,200 |
| 2024-09-30 |
Connelly Robert |
CEO, President and Director |
RSU-Zuteilung |
91,600 |
$5.03 |
$460.75K |
91,600 |
| 2024-09-30 |
Demuth Peter |
Chief Scientific Officer |
RSU-Zuteilung |
29,800 |
$5.03 |
$149.89K |
29,800 |
| 2024-08-12 |
Chudnovsky Yekaterina |
10 Percent Owner |
Informierter Kauf |
3,442,341 |
$5.81 |
$20M |
3,442,341 |
| 2024-06-28 |
Venkatesan Jay |
Director |
Informierter Kauf |
50,000 |
$0.01 |
$500.00 |
50,000 |
| 2024-06-28 |
Chudnovsky Yekaterina |
10 Percent Owner |
Informierter Kauf |
1,600,000 |
$0.01 |
$16K |
1,600,000 |
| 2024-03-19 |
Chudnovsky Yekaterina |
10 Percent Owner |
Informierter Kauf |
1,032,702 |
$0.01 |
$10.33K |
1,032,702 |
| 2024-02-01 |
Haqq Christopher |
See Remarks |
RSU-Zuteilung |
28,200 |
$4.50 |
$126.9K |
28,200 |
| 2024-02-01 |
Connelly Robert |
CEO, President and Director |
RSU-Zuteilung |
225,137 |
$4.50 |
$1.01M |
225,137 |
| 2024-02-01 |
Piekos Brian |
Chief Financial Officer |
RSU-Zuteilung |
43,225 |
$4.50 |
$194.51K |
43,225 |
| 2024-02-01 |
Demuth Peter |
Chief Scientific Officer |
RSU-Zuteilung |
342 |
$4.50 |
$1.54K |
342 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
